drugset / Trial / NCT05051163

Strategies to Reduce Mortality Among HIV-infected and HIV-exposed Children Admitted With Severe Acute Malnutrition

NCT05051163

Phase 2/3 Unknown 300 enrolled Makerere University
RandomizedParallel-groupOpen-labelTreatment

Summary

This study to investigate whether empiric use of an antibiotic with greater antimicrobial sensitivity (ceftriaxone) than standard-of-care (ampicillin plus gentamicin) will reduce mortality among HIV-infected/HEU children admitted to Mwanamugimu Nutrition Unit, Mulago Hospital, Kampala, Uganda.

Timeline

Start
2021-06-14
Primary completion
2024-06-14
Completion
2024-06-14

Drugs

EvaluationDrugModalityDoseRoute
Comparator Ampicillin Unknown 50 mg/kg Intravenous
Subject Ceftriaxone Other / unclassified 50 mg/kg Intravenous
Subject Ceftriaxone Other / unclassified 75 mg/kg Intravenous
Comparator Gentamicin Small molecule 5 mg/kg Intravenous